DoseMe’s Chief Science and Strategy Officer, Sharmeen Roy, Named One of the “Top 50 Women Leaders in Healthcare Technology of 2024”
In this article:
Jupiter, FL – February 7, 2025
DoseMe, a leader in model-informed precision dosing (MIPD), is proud to announce that Sharmeen Roy, Chief Science and Strategy Officer, has been recognized as one of the “Top 50 Women Leaders in Healthcare Technology of 2024” by The Healthcare Technology Report.
This prestigious recognition highlights leaders who have demonstrated outstanding executive performance, driving business growth, product innovation, and organizational impact. Hundreds of nominations were submitted, with winners selected based on long-term industry contributions, strategic leadership, and advancements in healthcare technology.
“I am truly honored to receive this award and to be recognized alongside such an inspiring group of women leaders who are driving innovation in healthcare technology,” said Roy. “This recognition is not just a reflection of the work we do at DoseMe, but a testament to the growing influence of women in shaping the future of precision medicine. By advancing clinical decision support tools that integrate precision dosing, Bayesian modeling, and real-time monitoring, we’re helping healthcare teams deliver more personalized, effective treatments. Together, women in technology are transforming patient care—driving better outcomes for both patients and healthcare systems one innovation at a time.”
Since joining DoseMe in 2022, Roy has been instrumental in advancing precision dosing and strengthening DoseMe’s impact within the healthcare industry.
“Sharmeen has consistently demonstrated an unwavering commitment to improving healthcare by understanding the challenges faced by healthcare professionals —from the patient bedside to the pharmacy,” said Paul Edwards, CEO of DoseMe. “Her leadership goes beyond operational excellence—she is shaping the future of precision dosing and driving innovation that supports a more personalized, patient-centric approach to medicine.”
The Healthcare Technology Report provides market insights, business news, and investment updates related to the healthcare technology sector.
For more information on the award and the full list of honorees, please visit “Top 50 Women Leaders in Healthcare Technology of 2024” by The Healthcare Technology Report
About DoseMe
DoseMe combines smart technology with science, leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories